{"id":34113,"date":"2022-09-13T14:11:05","date_gmt":"2022-09-13T06:11:05","guid":{"rendered":"http:\/\/biopioneer.com.tw\/?p=34113"},"modified":"2025-11-15T15:33:14","modified_gmt":"2025-11-15T07:33:14","slug":"%e6%bf%95%e9%bb%b4%e7%b4%a0hygromycin-b-cas31282-04-9-apexbio%e8%b2%a8%e8%99%9fa2515","status":"publish","type":"post","link":"https:\/\/biopioneer.com.tw\/?p=34113","title":{"rendered":"\u6fd5\u9ef4\u7d20(Hygromycin B) | CAS#31282-04-9 APExBIO\u8ca8\u865fA2515"},"content":{"rendered":"

\u6297\u83cc\u5291\u7cfb\u5217\u5546\u54c1->>\u6fd5\u9ef4\u7d20(Hygromycin B)<\/span><\/span><\/span><\/span><\/strong><\/p>\n

APExBIO Technology LLC \u662f\u4e00\u5bb6\u9818\u5148\u7684\u5c0f\u5206\u5b50\u6291\u5236\u5291 (Small Molecule Inhibitors)\/\u6d3b\u5316\u5291(Activators)\u3001\u5316\u5408\u7269\u5eab( Compound Libraries)\u3001\u80dc\u80bd(Peptides)\u3001\u6aa2\u6e2c\u8a66\u5291\u76d2(Assay Kits)\u3001\u87a2\u5149\u6a19\u8a18(Fluorescent Label)\u3001\u9176(Enzymes)\u3001\u4fee\u98fe\u6838\u82f7\u9178(Modified Nucleotides)\u3001mRNA \u5408\u6210\u4ee5\u53ca\u5404\u7a2e\u5206\u5b50\u751f\u7269\u5b78\u5de5\u5177\u7684\u4f9b\u61c9\u5546\u3002APExBIO\u63d0\u4f9b\u5ee3\u6cdb\u7684\u7522\u54c1\u7dda\uff0c\u6db5\u84cb 20 \u591a\u500b\u4e0d\u540c\u7684\u7814\u7a76\u9818\u57df\uff0c\u4f8b\u5982\u764c\u75c7(cancer)\u3001\u514d\u75ab\u5b78(immunology)\u3001\u795e\u7d93\u79d1\u5b78(neurosciences)\u3001\u7d30\u80de\u51cb\u4ea1(apoptosis)\u548c\u8868\u89c0\u907a\u50b3\u5b78(epigenetics)\u7b49\u3002\u516c\u53f8\u7e3d\u90e8\u4f4d\u65bc\u7f8e\u570b\u5fb7\u5dde\u4f11\u58eb\u9813USA (Houston, Texas)\uff0c\u81f4\u529b\u65bc\u670d\u52d9\u5168\u7403\u5ba2\u6236\u3002\u9ad8\u5ea6\u91cd\u8996\u7522\u54c1\u54c1\u8cea\u3002\u6240\u6709\u7522\u54c1\u5747\u9075\u5faa\u56b4\u683c\u7684\u751f\u7522\u6307\u5357\uff0c\u4e26\u9644\u6709\u5206\u6790\u8b49\u66f8\u3001HPLC\u3001\u8cea\u8b5c(Mass Spectrum)\u548cHMNR\u4ee5\u53ca\u9ad4\u5916\u9a57\u8b49(in vitro validation)\u3002 APExBIO\u7522\u54c1\u5df2\u88ab\u300aNature\u300b\u3001\u300aCell\u300b\u548c\u300aScience\u300b\u7b49\u773e\u591a\u9802\u7d1a\u540c\u884c\u8a55\u5be9\u671f\u520a\u5f15\u7528\u3002>>\u66f4\u591aAPExBio\u5546\u54c1<\/span><\/strong><\/em><\/span><\/a><\/p>\n

<\/p>\n

\u6fd5\u9ef4\u7d20(Hygromycin B) | CAS#31282-04-9 APExBIO\u8ca8\u865fA2515<\/span><\/strong><\/span><\/a><\/span><\/p>\n

Hygromycin B is a selective antibiotic.<\/p>\n

\u6297\u751f\u7d20(Antibiotics)\u662f\u4e00\u7a2e\u7528\u65bc\u6cbb\u7642\u548c\u9810\u9632\u7d30\u83cc\u611f\u67d3\u7684\u6297\u83cc\u5291\u3002\u6fd5\u9ef4\u7d20(Hygromycin B)\u662f\u4e00\u7a2e\u9078\u64c7\u6027\u6297\u751f\u7d20\u3002\u5c0d\u5927\u591a\u6578\u7d30\u83cc(bacteria)\u3001\u771f\u83cc\u548c\u9ad8\u7b49\u771f\u6838\u751f\u7269\u6709\u6548\u7684\u6297\u751f\u7d20\u3002 \u6fd5\u9ef4\u7d20(Hygromycin B) \u5728 30S \u4e9e\u57fa\u5167\u6709\u4e00\u500b\u55ae\u4e00\u7684\u7d50\u5408\u4f4d\u9ede\uff0c\u9019\u8207\u5176\u55ae\u76f8\u6548\u61c9\u4e00\u81f4\u3002\u7d50\u5408\u4f4d\u9ede\u4ee5\u9ad8\u5ea6\u5e8f\u5217\u7279\u7570\u6027\u7684\u65b9\u5f0f\u4f4d\u65bc\u87ba\u65cb\u7684\u5927\u6e9d\u4e2d\u6fd5\u9ef4\u7d20(Hygromycin B)\u901a\u904e\u6291\u5236\u5ef6\u4f38\u7684\u6613\u4f4d\u6b65\u9a5f\u4e26\u5c0e\u81f4 70S \u6838\u91a3\u9ad4\u4e2d mRNA \u7684\u932f\u8aa4\u7ffb\u8b6f\u4f86\u6291\u5236\u86cb\u767d\u8cea\u5408\u6210 [1]\u3002 Hygromycin B \u9078\u64c7\u6027\u6291\u5236 70S \u6838\u91a3\u9ad4\u4e0a\u6838\u91a3\u9ad4 ATP \u9176 (RbbA) \u7684\u6d3b\u6027\uff0c\u4e26\u5728\u751f\u7406\u6fc3\u5ea6\u4e0b\u5f9e 70S \u6838\u91a3\u9ad4\u91cb\u653e RbbA\u3002 RbbA \u589e\u5f37 16S rRNA \u958b\u95dc\u87ba\u65cb\u5340\u57df\u7684 A889 \u548c G890 \u7684\u53cd\u61c9\u6027\u3002\u6b64\u5916\uff0c\u6fd5\u9ef4\u7d20(Hygromycin B) \u5728\u89e3\u78bc\u5340\u4fdd\u8b77 G1494 \u548c A1408\u3002<\/p>\n\n\n\n\n\n\n\n\n\n\n\n\n\n
Physical Appearance<\/td>\nA solid<\/td>\n<\/tr>\n
Storage<\/td>\nStore at -20\u00b0C<\/td>\n<\/tr>\n
M.Wt<\/td>\n527.5<\/td>\n<\/tr>\n
Cas No.<\/td>\n31282-04-9<\/td>\n<\/tr>\n
Formula<\/td>\nC20<\/sub>H37<\/sub>N3<\/sub>O13<\/sub><\/td>\n<\/tr>\n
Solubility<\/td>\n\u226526.38 mg\/mL in H2O; \u22655.35 mg\/mL in EtOH; \u22659.14 mg\/mL in DMSO<\/td>\n<\/tr>\n
Chemical Name<\/td>\n(3’R,3aS,4S,4’R,5’R,6R,6’R,7S,7aS)-4-[(1R,2S,3R,5S,6R)-3-amino-2,6-dihydroxy-5-(methylamino)cyclohexyl]oxy-6′-[(1S)-1-amino-2-hydroxyethyl]-6-(hydroxymethyl)spiro[4,6,7,7a-tetrahydro-3aH-[1,3]dioxolo[4,5-c]pyran-2,2′-oxane]-3′,4′,5′,7-tetrol<\/td>\n<\/tr>\n
SDF<\/td>\nDownload SDF<\/a><\/td>\n<\/tr>\n
Canonical SMILES<\/td>\nCNC1CC(C(C(C1O)OC2C3C(C(C(O2)CO)O)OC4(O3)C(C(C(C(O4)C(CO)N)O)O)O)O)N<\/td>\n<\/tr>\n
Shipping Condition<\/td>\nShip with blue ice, or upon other requests.<\/td>\n<\/tr>\n
General tips<\/td>\nFor obtaining a higher solubility, please warm the tube at 37\u00b0C and shake it in the ultrasonic bath for a while. We do not recommend long-term storage for the solution, please use it up soon.<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

<\/h4>\n

<\/p>\n

APExBIO\u53f0\u7063\u4ee3\u7406\u5546:\u00a0 <\/span><\/span><\/strong><\/span><\/a>https:\/\/www.apexbt.com\/<\/span><\/span><\/a><\/span><\/p>\n

APExBIO\u63d0\u4f9b\u512a\u8cea\u7684\u80dc\u80bd\u548c\u751f\u7269\u5206\u6790\u8a66\u5291\uff0c\u5ee3\u6cdb\u7522\u54c1\u7dda\u5982Protease\u3001Chromatin\/Epigenetics\u8868\u89c0\u907a\u50b3\u5b78\u3001MAPK Signal\u3001DNA Damege\/DNA repair\u3001\u7d30\u80de\u51cb\u4ea1\u3001\u816b\u7624\u751f\u7269\u5b78\u3001Stem cell\u7b49\u7814\u7a76\u9818\u57df\uff0c \u9084\u63d0\u4f9b\u5b9a\u5236\u7684\u670d\u52d9\uff0c\u5305\u62ec\u591a\u80bd\u5408\u6210\uff0c\u6297\u9ad4\u7684\u751f\u7522\u548c\u6aa2\u6e2c\u7684\u767c\u5c55\u3002\u7522\u54c1\u7ddaDNA\/RNA prep kit\u3001Drug Screening panel\u3001Bioactive peptides\u3001Growth factors\u3001Biotinylation Reagents\u3001tag peptides\u3001amino Acids\u3001Growth factors\u7b49\u3002APExBIO\u7522\u54c1\u8cea\u91cf\u90fd\u4f34\u96a8\u8457\u8b49\u66f8\u7684\u5206\u6790\uff0c\u9ad8\u6548\u6db2\u76f8\u8272\u8b5c\uff0c\u8cea\u8b5c\uff0c\u548cHMNR\u6578\u64da\u3002<\/p>\n

<\/p>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
Cat#<\/td>\nProduct Name<\/td>\n<\/tr>\n
A8743<\/td>\nSYBR Safe DNA Gel Stain<\/td>\n<\/tr>\n
A6001<\/td>\n3X (DYKDDDDK) Peptide<\/td>\n<\/tr>\n
K1018<\/td>\nCell Counting Kit-8 (CCK-8)<\/td>\n<\/tr>\n
A1902<\/td>\nZ-VAD-FMK<\/td>\n<\/tr>\n
A3008<\/td>\nY-27632 dihydrochloride<\/td>\n<\/tr>\n
A6002<\/td>\nDYKDDDDK tag Peptide<\/td>\n<\/tr>\n
B8362<\/td>\n2’3′-cGAMP (sodium salt)<\/td>\n<\/tr>\n
F4002<\/td>\nPhos binding reagent (Phosbind) acrylamide<\/td>\n<\/tr>\n
A8011<\/td>\nBiotin-tyramide<\/td>\n<\/tr>\n
A2585<\/td>\nMG-132<\/td>\n<\/tr>\n
F4005<\/td>\nPrestained Protein Marker (Triple color, EDTA free, 10-250 kDa)<\/td>\n<\/tr>\n
B1274<\/td>\nAP20187<\/td>\n<\/tr>\n
K1007<\/td>\nProtease Inhibitor Cocktail(EDTA-Free,100X in DMSO)<\/td>\n<\/tr>\n
B8226<\/td>\nInstaBlue Protein Stain Solution<\/td>\n<\/tr>\n
A3011<\/td>\nCHIR-99021 (CT99021)<\/td>\n<\/tr>\n
A3007<\/td>\nABT-263 (Navitoclax)<\/td>\n<\/tr>\n
B1524<\/td>\nErastin<\/td>\n<\/tr>\n
B6055<\/td>\nTCEP hydrochloride<\/td>\n<\/tr>\n
K1031<\/td>\nPhusion high-fidelity DNA polymerase<\/td>\n<\/tr>\n
B1387<\/td>\n(-)-Blebbistatin<\/td>\n<\/tr>\n
B4664<\/td>\nT-5224<\/td>\n<\/tr>\n
A8183<\/td>\nTrichostatin A (TSA)<\/td>\n<\/tr>\n
B3699<\/td>\nISRIB (trans-isomer)<\/td>\n<\/tr>\n
A1910<\/td>\nBromodomain Inhibitor, (+)-JQ1<\/td>\n<\/tr>\n
B1293<\/td>\nY-27632<\/td>\n<\/tr>\n
A8167<\/td>\nRapamycin (Sirolimus)<\/td>\n<\/tr>\n
A7024<\/td>\nHOAt<\/td>\n<\/tr>\n
A7025<\/td>\nHOBt (anhydrous)<\/td>\n<\/tr>\n
A8331<\/td>\nBleomycin Sulfate<\/td>\n<\/tr>\n
A4333<\/td>\nCPI-613<\/td>\n<\/tr>\n
K1070<\/td>\n2X SYBR Green qPCR Master Mix<\/td>\n<\/tr>\n
A8005<\/td>\nSulfo-NHS-SS-Biotin<\/td>\n<\/tr>\n
B4653<\/td>\nBV6<\/td>\n<\/tr>\n
B5965<\/td>\nTamoxifen<\/td>\n<\/tr>\n
A1901<\/td>\nQ-VD-OPh hydrate<\/td>\n<\/tr>\n
A8950<\/td>\nUM 171<\/td>\n<\/tr>\n
K1046<\/td>\nRNase Inhibitor, Murine<\/td>\n<\/tr>\n
A3317<\/td>\nClozapine N-oxide (CNO)<\/td>\n<\/tr>\n
A2614<\/td>\nBortezomib (PS-341)<\/td>\n<\/tr>\n
A8003<\/td>\nSulfo-NHS-LC-Biotin<\/td>\n<\/tr>\n
A4154<\/td>\nOlaparib (AZD2281, Ku-0059436)<\/td>\n<\/tr>\n
A8012<\/td>\nBiotin-XX Tyramide Reagent<\/td>\n<\/tr>\n
K1101<\/td>\nPreScission Protease (PSP)<\/td>\n<\/tr>\n
A8627<\/td>\nBafilomycin A1<\/td>\n<\/tr>\n
A8001<\/td>\nSulfo-NHS-Biotin<\/td>\n<\/tr>\n
A3017<\/td>\nDasatinib (BMS-354825)<\/td>\n<\/tr>\n
A2576<\/td>\nE-64<\/td>\n<\/tr>\n
K1051<\/td>\nCy3 TSA Fluorescence System Kit<\/td>\n<\/tr>\n
K1034<\/td>\n2X Taq PCR Master Mix (with dye)<\/td>\n<\/tr>\n
B7972<\/td>\nPseudo-UTP<\/td>\n<\/tr>\n
A8173<\/td>\nRomidepsin (FK228, depsipeptide)<\/td>\n<\/tr>\n
A4219<\/td>\nBirinapant (TL32711)<\/td>\n<\/tr>\n
A4371<\/td>\nFerrostatin-1 (Fer-1)<\/td>\n<\/tr>\n
A8200<\/td>\nDAPT (GSI-IX)<\/td>\n<\/tr>\n
A8249<\/td>\nSB 431542<\/td>\n<\/tr>\n
K1008<\/td>\nProtease Inhibitor Cocktail (EDTA-Free, 200X in DMSO)<\/td>\n<\/tr>\n
A3133<\/td>\nA 83-01<\/td>\n<\/tr>\n
A8192<\/td>\nStaurosporine<\/td>\n<\/tr>\n
B1054<\/td>\nResiquimod (R-848)<\/td>\n<\/tr>\n
A3018<\/td>\nTrametinib (GSK1120212)<\/td>\n<\/tr>\n
A8184<\/td>\nAICAR<\/td>\n<\/tr>\n
K1025<\/td>\nDirect Mouse Genotyping Kit<\/td>\n<\/tr>\n
A2606<\/td>\nEpoxomicin<\/td>\n<\/tr>\n
A6006<\/td>\nHexa His tag peptide<\/td>\n<\/tr>\n
A4393<\/td>\nPaclitaxel (Taxol)<\/td>\n<\/tr>\n
A8315<\/td>\nNU7441 (KU-57788)<\/td>\n<\/tr>\n
A4213<\/td>\nNecrostatin-1<\/td>\n<\/tr>\n
A8885<\/td>\nRo 3306<\/td>\n<\/tr>\n
L1021<\/td>\nDiscoveryProbe\u2122 FDA-approved Drug Library<\/td>\n<\/tr>\n
B1464<\/td>\nKPT-330<\/td>\n<\/tr>\n
A8815<\/td>\nSM-164<\/td>\n<\/tr>\n
B4879<\/td>\nBlasticidin S HCl<\/td>\n<\/tr>\n
A8793<\/td>\nN3-kethoxal<\/td>\n<\/tr>\n
K1047<\/td>\nHyperScribe\u2122 T7 High Yield RNA Synthesis Kit<\/td>\n<\/tr>\n
A6004<\/td>\nInfluenza Hemagglutinin (HA) Peptide<\/td>\n<\/tr>\n
B1036<\/td>\nMLN4924<\/td>\n<\/tr>\n
A8178<\/td>\nPanobinostat (LBH589)<\/td>\n<\/tr>\n
A3963<\/td>\nA-769662<\/td>\n<\/tr>\n
A3847<\/td>\nSU5416<\/td>\n<\/tr>\n
B3252<\/td>\nDorsomorphin (Compound C)<\/td>\n<\/tr>\n
B4758<\/td>\nBAPTA-AM<\/td>\n<\/tr>\n
A2513<\/td>\nGeneticin, G-418 Sulfate<\/td>\n<\/tr>\n
B6004<\/td>\nPX-478 2HCl<\/td>\n<\/tr>\n
A8955<\/td>\nZ-YVAD-FMK<\/td>\n<\/tr>\n
A8193<\/td>\nABT-737<\/td>\n<\/tr>\n
B2083<\/td>\nCaspofungin Acetate<\/td>\n<\/tr>\n
A8002<\/td>\nNHS-Biotin<\/td>\n<\/tr>\n
A8337<\/td>\nCX-5461<\/td>\n<\/tr>\n
A8312<\/td>\nTorin 1<\/td>\n<\/tr>\n
A2570<\/td>\nLeupeptin, Microbial<\/td>\n<\/tr>\n
K2170<\/td>\nAlanine Aminotransferase (ALT or SGPT) Activity Colorimetric\/Fluorometric Assay Kit<\/td>\n<\/tr>\n
A4381<\/td>\nFK866 (APO866)<\/td>\n<\/tr>\n
B2143<\/td>\nTacrolimus (FK506)<\/td>\n<\/tr>\n
A2571<\/td>\nPepstatin A<\/td>\n<\/tr>\n
k1072<\/td>\nFirst-Strand cDNA Synthesis Kit<\/td>\n<\/tr>\n
A3003<\/td>\nMDV3100 (Enzalutamide)<\/td>\n<\/tr>\n
B5997<\/td>\nDyngo-4a<\/td>\n<\/tr>\n
A3742<\/td>\nPyridostatin<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

\u00a0\"\u539f\u5ee0\u578b\u9304\"<\/a><\/strong><\/p>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
A3173<\/td>\nAMD-070<\/td>\n558447-26-0<\/td>\n98.00%<\/td>\nCXCR4 antagonist,potent and selective<\/td>\n<\/tr>\n
A3174<\/td>\nAMD-070 hydrochloride<\/td>\n880549-30-4<\/td>\n98.00%<\/td>\nCXCR4 antagonist,potent and selective<\/td>\n<\/tr>\n
A3176<\/td>\nAmpalex<\/td>\n154235-83-3<\/td>\n98.54%<\/td>\nAmpakine and nootropic<\/td>\n<\/tr>\n
A3177<\/td>\nAN-2690<\/td>\n174671-46-6<\/td>\n98.60%<\/td>\nAntifungal agent<\/td>\n<\/tr>\n
A3178<\/td>\nAN-2728<\/td>\n906673-24-3<\/td>\n99.33%<\/td>\nPDE4 inhibitor,anti-inflammatory compound<\/td>\n<\/tr>\n
A3179<\/td>\nAnamorelin<\/td>\n249921-19-5<\/td>\n99.68%<\/td>\nGhrelin receptor agonist, synthetic, orally active<\/td>\n<\/tr>\n
A3182<\/td>\nAnguizole<\/td>\n442666-98-0<\/td>\n98.00%<\/td>\nInhibitor of HCV replication<\/td>\n<\/tr>\n
A3184<\/td>\nAR-A014418<\/td>\n487021-52-3<\/td>\n98.34%<\/td>\nGSK3\u03b2 inhibitor, ATP-competitive and selective<\/td>\n<\/tr>\n
A3185<\/td>\nAR-C155858<\/td>\n496791-37-8<\/td>\n99.52%<\/td>\nMCT1 and MCT2 inhibitor<\/td>\n<\/tr>\n
A3188<\/td>\nARRY-520 R enantiomer<\/td>\n885060-08-2<\/td>\n98.00%<\/td>\nKSP inhibitor<\/td>\n<\/tr>\n
A3189<\/td>\nAS 602801<\/td>\n848344-36-5<\/td>\n98.72%<\/td>\nJun Kinase Inhibitor<\/td>\n<\/tr>\n
A3190<\/td>\nASC-J9<\/td>\n52328-98-0<\/td>\n98.00%<\/td>\nAR degradation enhancer,antiumor agent<\/td>\n<\/tr>\n
A3191<\/td>\nAscomycin(FK 520)<\/td>\n104987-12-4<\/td>\n98.00%<\/td>\nMacrolide immunosuppressant,FK-520 analog<\/td>\n<\/tr>\n
A3192<\/td>\nAsenapine hydrochloride<\/td>\n1412458-61-7<\/td>\n98.00%<\/td>\nAtypical antipsychotic<\/td>\n<\/tr>\n
A3193<\/td>\nASP3026<\/td>\n1097917-15-1<\/td>\n99.38%<\/td>\nALK inhibitor,potent and selective<\/td>\n<\/tr>\n
A3194<\/td>\nAST 487<\/td>\n630124-46-8<\/td>\n99.29%<\/td>\nRET kinase inhibitor<\/td>\n<\/tr>\n
A3195<\/td>\nAsunaprevir (BMS-650032)<\/td>\n630420-16-5<\/td>\n99.80%<\/td>\nNS3 protease inhibitor<\/td>\n<\/tr>\n
A3196<\/td>\nAT-101<\/td>\n90141-22-3<\/td>\n98.00%<\/td>\nBH3-mimetic,gossypol enantiomer<\/td>\n<\/tr>\n
A3197<\/td>\nAT7519 Hydrochloride<\/td>\n902135-91-5<\/td>\n99.80%<\/td>\nMulti-CDK inhibitor<\/td>\n<\/tr>\n
A3198<\/td>\nAT7519 trifluoroacetate<\/td>\n1431697-85-6<\/td>\n98.00%<\/td>\nCDK\/cyclin inhibitor<\/td>\n<\/tr>\n
A3199<\/td>\nAT7867 dihydrochloride<\/td>\n1431697-86-7<\/td>\n98.00%<\/td>\nAkt1 and p70S6K\/PKA inhibitor<\/td>\n<\/tr>\n
A3201<\/td>\nAtrasentan hydrochloride<\/td>\n195733-43-8<\/td>\n98.00%<\/td>\nEndothelin receptor antagonist<\/td>\n<\/tr>\n
A3202<\/td>\nAvermectin B1<\/td>\n71751-41-2<\/td>\n98.00%<\/td>\nInsecticide<\/td>\n<\/tr>\n
A3206<\/td>\nAVL-292<\/td>\n1202757-89-8<\/td>\n98.27%<\/td>\nBtk inhibitor<\/td>\n<\/tr>\n
A3208<\/td>\nAvosentan<\/td>\n290815-26-8<\/td>\n98.00%<\/td>\nETA receptor antagonist<\/td>\n<\/tr>\n
A3209<\/td>\nAXL1717<\/td>\n477-47-4<\/td>\n98.07%<\/td>\nIGF-1R inhibitor,orally active<\/td>\n<\/tr>\n
A3210<\/td>\nAZ20<\/td>\n1233339-22-4<\/td>\n99.93%<\/td>\nATR inhibitor,potent and selective<\/td>\n<\/tr>\n
A3214<\/td>\nAZD1152<\/td>\n722543-31-9<\/td>\n98.78%<\/td>\nAurora B kinase inhibitor,highly potent and selective<\/td>\n<\/tr>\n
A3215<\/td>\nAZD7687<\/td>\n1166827-44-6<\/td>\n98.00%<\/td>\nDGAT inhibitor,potent and selective<\/td>\n<\/tr>\n
A3216<\/td>\nBalaglitazone<\/td>\n199113-98-9<\/td>\n99.62%<\/td>\nPPAR-\u03b3 partial agonist<\/td>\n<\/tr>\n
A3217<\/td>\nBalapiravir<\/td>\n690270-29-2<\/td>\n98.00%<\/td>\nPolymerase inhibitor,anti-HCV<\/td>\n<\/tr>\n
A3218<\/td>\nBAM7<\/td>\n331244-89-4<\/td>\n98.00%<\/td>\nBAX activator,direct and selective<\/td>\n<\/tr>\n
A3219<\/td>\nBAN ORL 24<\/td>\n475150-69-7<\/td>\n98.00%<\/td>\nNOP receptor antagonist, potent and selective<\/td>\n<\/tr>\n
A3220<\/td>\nBardoxolone<\/td>\n218600-44-3<\/td>\n99.55%<\/td>\nOnce-a-day treatment for CKD<\/td>\n<\/tr>\n
A3221<\/td>\nBardoxolone methyl<\/td>\n218600-53-4<\/td>\n98.75%<\/td>\nIKK inhibitor, potent antioxidant inflammation modulator<\/td>\n<\/tr>\n
A3222<\/td>\nBaricitinib phosphate<\/td>\n1187595-84-1<\/td>\n99.59%<\/td>\nJAK1\/JAK2 inhibitor<\/td>\n<\/tr>\n
A3227<\/td>\nBAY 61-3606<\/td>\n732983-37-8<\/td>\n98.45%<\/td>\nSyk Inhibitor<\/td>\n<\/tr>\n
A3228<\/td>\nBAY 61-3606 dihydrochloride<\/td>\n648903-57-5<\/td>\n98.00%<\/td>\nSyk tyrosine kinase inhibitor<\/td>\n<\/tr>\n
A3230<\/td>\nBay 65-1942 HCl salt<\/td>\n600734-06-3<\/td>\n98.00%<\/td>\nIKK\u03b2 kinase inhibitor<\/td>\n<\/tr>\n
A3232<\/td>\nBazedoxifene<\/td>\n198481-32-2<\/td>\n98.00%<\/td>\nEstrogen receptor modulator<\/td>\n<\/tr>\n
A3236<\/td>\nBenfotiamine<\/td>\n22457-89-2<\/td>\n99.76%<\/td>\nDrug for painful nerve condition<\/td>\n<\/tr>\n
A3237<\/td>\nBetulinic acid<\/td>\n472-15-1<\/td>\n98.00%<\/td>\nAnti-HIV and antitumor compound,pentacyclic triterpenoid<\/td>\n<\/tr>\n
A3238<\/td>\nBEZ235 Tosylate<\/td>\n1028385-32-1<\/td>\n98.28%<\/td>\nMTOR\/P13K inhibitor<\/td>\n<\/tr>\n
A3239<\/td>\nB-HT 920<\/td>\n36085-73-1<\/td>\n98.00%<\/td>\nD2 receptor agonist<\/td>\n<\/tr>\n
A3240<\/td>\nBIBX 1382<\/td>\n196612-93-8<\/td>\n98.00%<\/td>\nEGFR inhibitor,potent and selective<\/td>\n<\/tr>\n
A3241<\/td>\nBilobalide<\/td>\n33570-04-6<\/td>\n98.00%<\/td>\nNeuroprotective agent<\/td>\n<\/tr>\n
A3242<\/td>\nBitopertin<\/td>\n845614-11-1<\/td>\n99.70%<\/td>\nGlycine reuptake inhibitor(GlyT1)<\/td>\n<\/tr>\n
A3244<\/td>\nBivalirudin Trifluoroacetate<\/td>\n128270-60-0<\/td>\n98.07%<\/td>\nReversible thrombin inhibitor<\/td>\n<\/tr>\n
A3246<\/td>\nBMN-673 8R,9S<\/td>\n1207456-00-5<\/td>\n99.75%<\/td>\nInactive form of BMN 673, used as negative control<\/td>\n<\/tr>\n
A3248<\/td>\nBMS345541 hydrochloride<\/td>\n547757-23-3<\/td>\n99.57%<\/td>\nIKK inhibitor,highly selective<\/td>\n<\/tr>\n
A3250<\/td>\nBMS-509744<\/td>\n439575-02-7<\/td>\n98.00%<\/td>\nItk inhibitor,potent and selective<\/td>\n<\/tr>\n
A3252<\/td>\nBMS-599626 Hydrochloride<\/td>\n873837-23-1<\/td>\n99.58%<\/td>\nEGFR\/HER2 inhibitor,potent and selective<\/td>\n<\/tr>\n
A3253<\/td>\nBMS-626529<\/td>\n701213-36-7<\/td>\n98.01%<\/td>\nHIV-1 attachment inhibitor<\/td>\n<\/tr>\n
A3254<\/td>\nBMS-663068<\/td>\n864953-29-7<\/td>\n98.00%<\/td>\nHIV-1 attachment inhibitor<\/td>\n<\/tr>\n
A3256<\/td>\nBMS-690514<\/td>\n859853-30-8<\/td>\n98.00%<\/td>\nHER\/EGFR inhibitor<\/td>\n<\/tr>\n
A3257<\/td>\nBMS-790052 dihydrochloride<\/td>\n1009119-65-6<\/td>\n99.81%<\/td>\nHCV NS5A inhibitor<\/td>\n<\/tr>\n
A3258<\/td>\nBMS-833923<\/td>\n1059734-66-5<\/td>\n99.84%<\/td>\nSmoothened inhibitor<\/td>\n<\/tr>\n
A3259<\/td>\nBMS-927711<\/td>\n1289023-67-1<\/td>\n98.99%<\/td>\nCGRP receptor antagonist<\/td>\n<\/tr>\n
A3260<\/td>\nBMX-IN-1<\/td>\n1431525-23-3<\/td>\n97.99%<\/td>\nBMX (also termed ETK) kinase inhibitor<\/td>\n<\/tr>\n
A3261<\/td>\nBoceprevir<\/td>\n394730-60-0<\/td>\n98.00%<\/td>\nHCV protease inhibitor,potent and selective<\/td>\n<\/tr>\n
A3263<\/td>\nBRAF inhibitor<\/td>\n918505-61-0<\/td>\n98.00%<\/td>\nPotent B-raf inhibitor<\/td>\n<\/tr>\n
A3264<\/td>\nB-Raf inhibitor<\/td>\n1315330-11-0<\/td>\n98.00%<\/td>\nA B-Raf inhibitor<\/td>\n<\/tr>\n
A3265<\/td>\nBrassinolide<\/td>\n72962-43-7<\/td>\n98.00%<\/td>\nPlant growth regulator<\/td>\n<\/tr>\n
A3266<\/td>\nBS-181<\/td>\n1092443-52-1<\/td>\n98.00%<\/td>\nCDK7 inhibitor,highly selective<\/td>\n<\/tr>\n
A3268<\/td>\nCAL-130 Hydrochloride<\/td>\n1431697-78-7<\/td>\n98.00%<\/td>\nPI3K inhibitor<\/td>\n<\/tr>\n
A3270<\/td>\nCalcifediol monohydrate<\/td>\n63283-36-3<\/td>\n99.43%<\/td>\nPrehormone;vitamin D3 metabolite<\/td>\n<\/tr>\n
A3271<\/td>\nCalcipotriol<\/td>\n112965-21-6<\/td>\n98.00%<\/td>\nVitamin D3 analog,regulates cell differentiation and proliferation<\/td>\n<\/tr>\n
A3275<\/td>\nCalcium-Sensing Receptor Antagonists I<\/td>\n478963-79-0<\/td>\n98.00%<\/td>\nCaSR antagonist<\/td>\n<\/tr>\n
A3276<\/td>\nCanertinib dihydrochloride<\/td>\n289499-45-2<\/td>\n99.72%<\/td>\nPan-ErbB inhibitor, potent and selective<\/td>\n<\/tr>\n
A3277<\/td>\nCapadenoson<\/td>\n544417-40-5<\/td>\n98.00%<\/td>\nAdenosine A1 receptor agonist<\/td>\n<\/tr>\n
A3278<\/td>\nNonivamide (Capsaicin Analog)<\/td>\n2444-46-4<\/td>\n99.53%<\/td>\nTRPV1 receptor agonist<\/td>\n<\/tr>\n
A3279<\/td>\nCapsazepine<\/td>\n138977-28-3<\/td>\n99.25%<\/td>\nTRPV1 ion channel antagonist<\/td>\n<\/tr>\n
A3282<\/td>\nCariprazine<\/td>\n839712-12-8<\/td>\n99.19%<\/td>\nD2\/D3 partial agonist,antipsychotic drug<\/td>\n<\/tr>\n
A3284<\/td>\nCathepsin S inhibitor<\/td>\n1373215-15-6<\/td>\n98.33%<\/td>\nBlocks MHCII antigen presentation<\/td>\n<\/tr>\n
A3285<\/td>\nCB 300919<\/td>\n289715-28-2<\/td>\n98.00%<\/td>\nPotential therapy for ovarian cancer<\/td>\n<\/tr>\n
A3286<\/td>\nCB30865<\/td>\n206275-15-2<\/td>\n98.00%<\/td>\nNampt inhibitor<\/td>\n<\/tr>\n
A3287<\/td>\nCC-401 hydrochloride<\/td>\n1438391-30-0<\/td>\n98.00%<\/td>\nJNK inhibitor<\/td>\n<\/tr>\n
A3288<\/td>\nCC-930<\/td>\n899805-25-5<\/td>\n98.00%<\/td>\nJNK inhibitor,potent and selective<\/td>\n<\/tr>\n
A3289<\/td>\nCCG-63802<\/td>\n620112-78-9<\/td>\n98.00%<\/td>\nRGS protein inhibitor<\/td>\n<\/tr>\n
A3290<\/td>\nCCG-63808<\/td>\n620113-73-7<\/td>\n98.00%<\/td>\nReversible RGS inhibitor<\/td>\n<\/tr>\n
A3291<\/td>\nCCT241533<\/td>\n1262849-73-9<\/td>\n98.00%<\/td>\nPotent Chk2 inhibitor<\/td>\n<\/tr>\n
A3292<\/td>\nCCT241533 hydrochloride<\/td>\n1431697-96-9<\/td>\n98.00%<\/td>\nCHK2 kinase inhibitor, novel<\/td>\n<\/tr>\n
A3293<\/td>\nCDK inhibitor II<\/td>\n1269815-17-9<\/td>\n98.00%<\/td>\nCDK inhibitor<\/td>\n<\/tr>\n
A3294<\/td>\nCDK9 inhibitor<\/td>\n1415559-43-1<\/td>\n98.00%<\/td>\nCDK9 inhibitor<\/td>\n<\/tr>\n
A3295<\/td>\nCDK9 inhibitor 2<\/td>\n1263369-28-3<\/td>\n98.00%<\/td>\nCDK9 inhibitor<\/td>\n<\/tr>\n
A3297<\/td>\nCEP-32496 hydrochloride<\/td>\n1227678-26-3<\/td>\n98.00%<\/td>\nB-Raf\/C-Raf inhibitor,highly potent<\/td>\n<\/tr>\n
A3297<\/td>\nCEP-32496 hydrochloride<\/td>\n1227678-26-3<\/td>\n98.00%<\/td>\nB-Raf\/C-Raf inhibitor,highly potent<\/td>\n<\/tr>\n
A3298<\/td>\nCetirizine<\/td>\n83881-51-0<\/td>\n99.65%<\/td>\nAntihistamine<\/td>\n<\/tr>\n
A3300<\/td>\nCevimeline hydrochloride hemihydrate<\/td>\n153504-70-2<\/td>\n98.00%<\/td>\nAgonist of muscarinic receptor (M1\/M3)<\/td>\n<\/tr>\n
A3302<\/td>\nCGI-1746<\/td>\n910232-84-7<\/td>\n98.00%<\/td>\nBtk inhibitor<\/td>\n<\/tr>\n
A3303<\/td>\nCGP60474<\/td>\n164658-13-3<\/td>\n98.00%<\/td>\nCDKs and PKC inhibitor, potent<\/td>\n<\/tr>\n
A3304<\/td>\nCGS 21680<\/td>\n120225-54-9<\/td>\n98.00%<\/td>\nAdenosine A2 receptor agonists,potent and selective<\/td>\n<\/tr>\n
A3305<\/td>\nCHAPS<\/td>\n75621-03-3<\/td>\n97.71%<\/td>\nZwitterionic detergent for membrane proteins,nondenaturing<\/td>\n<\/tr>\n
A3306<\/td>\nChelerythrine Chloride<\/td>\n3895-92-9<\/td>\n99.36%<\/td>\nPKC antagonist<\/td>\n<\/tr>\n
A3307<\/td>\nCHIR-090<\/td>\n728865-23-4<\/td>\n99.37%<\/td>\nPotent LpxC inhibitor<\/td>\n<\/tr>\n
A3308<\/td>\nCholine Fenofibrate<\/td>\n856676-23-8<\/td>\n99.92%<\/td>\nCholine salt of fenofibric acid<\/td>\n<\/tr>\n
A3309<\/td>\nCHR-6494<\/td>\n1333377-65-3<\/td>\n98.00%<\/td>\nHaspin inhibitor,potent ands selective<\/td>\n<\/tr>\n
A3310<\/td>\nchroman 1<\/td>\n1273579-40-0<\/td>\n98.00%<\/td>\nROCK II inhibitor, highly potent and selective<\/td>\n<\/tr>\n
A3311<\/td>\nCID-2858522<\/td>\n758679-97-9<\/td>\n98.00%<\/td>\nNF-\u03baB pathway inhibitor<\/td>\n<\/tr>\n
A3313<\/td>\nCinacalcet<\/td>\n226256-56-0<\/td>\n99.48%<\/td>\nCalcimimetic agent,orally active<\/td>\n<\/tr>\n
A3314<\/td>\nCinaciguat<\/td>\n329773-35-5<\/td>\n98.00%<\/td>\nSoluble guanylate cyclase (sGC) activators<\/td>\n<\/tr>\n
A3315<\/td>\nClemizole<\/td>\n442-52-4<\/td>\n99.06%<\/td>\nH1 histamine receptor antagonist<\/td>\n<\/tr>\n
A3316<\/td>\nClemizole hydrochloride<\/td>\n1163-36-6<\/td>\n99.73%<\/td>\nH1 histamine receptor antagonist<\/td>\n<\/tr>\n
A3317<\/td>\nClozapine N-oxide (CNO)<\/td>\n34233-69-7<\/td>\n99.74%<\/td>\nMetabolite of clozapine, used in chemogenetics.<\/td>\n<\/tr>\n
A3319<\/td>\nCMK<\/td>\n821794-90-5<\/td>\n98.00%<\/td>\nRSK2 kinase inhibitor<\/td>\n<\/tr>\n
A3320<\/td>\nCO-1686 (AVL-301)<\/td>\n1374640-70-6<\/td>\n99.28%<\/td>\nEGFR inhibitor<\/td>\n<\/tr>\n
A3321<\/td>\nCobimetinib<\/td>\n934660-93-2<\/td>\n99.71%<\/td>\nSelective MEK inhibitor<\/td>\n<\/tr>\n
A3322<\/td>\nCobimetinib (racemate)<\/td>\n934662-91-6<\/td>\n98.00%<\/td>\nSelective MEK inhibitor<\/td>\n<\/tr>\n
A3331<\/td>\nCP-809101 hydrochloride<\/td>\n1215721-40-6<\/td>\n98.00%<\/td>\n5-HT2C receptor agonist, potent and selective<\/td>\n<\/tr>\n
A3334<\/td>\nCTS-1027<\/td>\n193022-04-7<\/td>\n98.00%<\/td>\nMMPs inhibitor<\/td>\n<\/tr>\n
A3335<\/td>\nCurcumin<\/td>\n458-37-7<\/td>\n98.36%<\/td>\nTyrosinase inhibitor<\/td>\n<\/tr>\n
A3336<\/td>\nCVT-313<\/td>\n199986-75-9<\/td>\n98.04%<\/td>\nCdk2 inhibitor<\/td>\n<\/tr>\n
A3337<\/td>\nCX-6258<\/td>\n1202916-90-2<\/td>\n98.28%<\/td>\nPan-Pim kinases Inhibitor<\/td>\n<\/tr>\n
A3339<\/td>\nCYT387 sulfate salt<\/td>\n1056636-06-6<\/td>\n98.00%<\/td>\nJAK1\/JAK2 inhibitor<\/td>\n<\/tr>\n
A3340<\/td>\nCZC24832<\/td>\n1159824-67-5<\/td>\n98.00%<\/td>\nSelective PI3K-\u03b3 inhibitor<\/td>\n<\/tr>\n
A3342<\/td>\nD4476<\/td>\n301836-43-1<\/td>\n99.22%<\/td>\nCK1\/ALK5 inhibitor,specific and cell permeable<\/td>\n<\/tr>\n
A3343<\/td>\nD609<\/td>\n83373-60-8<\/td>\n98.00%<\/td>\nPC-PLC inhibitor<\/td>\n<\/tr>\n
A3344<\/td>\nD-64131<\/td>\n74588-78-6<\/td>\n98.00%<\/td>\nTubulin polymerization inhibitor<\/td>\n<\/tr>\n
A3345<\/td>\nDabigatran etexilate mesylate<\/td>\n872728-81-9<\/td>\n99.41%<\/td>\nDirect thrombin inhibitor,anticoagulant,prodrug of dabigatran<\/td>\n<\/tr>\n
A3346<\/td>\nDabigatran ethyl ester<\/td>\n429658-95-7<\/td>\n98.00%<\/td>\nThrombin activity inhibitor<\/td>\n<\/tr>\n
A3347<\/td>\nDabrafenib Mesylate (GSK-2118436)<\/td>\n1195768-06-9<\/td>\n99.78%<\/td>\nInhibitor of BRAF(V600) mutants<\/td>\n<\/tr>\n
A3348<\/td>\nDaminozide<\/td>\n1596-84-5<\/td>\n98.00%<\/td>\nKDM2A inhibitor<\/td>\n<\/tr>\n
A3349<\/td>\nDarapladib<\/td>\n356057-34-6<\/td>\n99.54%<\/td>\nLp-PLA2 inhibitor, selective and orally active<\/td>\n<\/tr>\n
A3351<\/td>\nDasatinib hydrochloride<\/td>\n854001-07-3<\/td>\n99.91%<\/td>\nMulti-BCR\/Abl and Src kinase inhibitor, oral active<\/td>\n<\/tr>\n
A3352<\/td>\nDaun02<\/td>\n290304-24-4<\/td>\n98.00%<\/td>\nCell viability inhibitor,DNA synthisis inhibitor<\/td>\n<\/tr>\n
A3353<\/td>\nDB07268<\/td>\n929007-72-7<\/td>\n98.84%<\/td>\nJNK1 inhibitor<\/td>\n<\/tr>\n
A3355<\/td>\nDeferasirox Fe3+ chelate<\/td>\n554435-83-5<\/td>\n98.00%<\/td>\nOral iron chelator<\/td>\n<\/tr>\n
A3356<\/td>\nDelafloxacin<\/td>\n189279-58-1<\/td>\n99.81%<\/td>\nFluoroquinolone antibiotic<\/td>\n<\/tr>\n
A3357<\/td>\nDelafloxacin meglumine<\/td>\n352458-37-8<\/td>\n98.00%<\/td>\nFluoroquinolone antibiotic agent<\/td>\n<\/tr>\n
A3358<\/td>\nDeltarasin<\/td>\n1440898-61-2<\/td>\n98.00%<\/td>\nKRAS-PDE\u03b4 interaction inhibitor<\/td>\n<\/tr>\n
A3359<\/td>\nDesmopressin<\/td>\n16679-58-6<\/td>\n98.66%<\/td>\nHemostatic and anti-diuretic<\/td>\n<\/tr>\n
A3360<\/td>\nDesmopressin Acetate<\/td>\n62288-83-9<\/td>\n98.73%<\/td>\nSynthetic analogue of arginine vasopressin<\/td>\n<\/tr>\n
A3363<\/td>\nDGAT-1 inhibitor<\/td>\n701232-20-4<\/td>\n99.64%<\/td>\nDiacylglycerol acyltransferase (DGAT1) inhibitor<\/td>\n<\/tr>\n
A3366<\/td>\nDipraglurant<\/td>\n872363-17-2<\/td>\n98.00%<\/td>\nmGluR5 antagonist<\/td>\n<\/tr>\n
A3368<\/td>\nDMAT<\/td>\n749234-11-5<\/td>\n98.60%<\/td>\nCK2 inhibitor,potent and selective<\/td>\n<\/tr>\n
A3369<\/td>\nDMP 777<\/td>\n157341-41-8<\/td>\n98.00%<\/td>\nLeukocyte elastase (HLE) inhibitor<\/td>\n<\/tr>\n
A3370<\/td>\nDocetaxel Trihydrate<\/td>\n148408-66-6<\/td>\n99.78%<\/td>\nDepolymerisation of microtubules inhibitor<\/td>\n<\/tr>\n
A3371<\/td>\nDoramectin<\/td>\n117704-25-3<\/td>\n97.08%<\/td>\nAntiparasitic antibiotic<\/td>\n<\/tr>\n
A3374<\/td>\nDronedarone<\/td>\n141626-36-0<\/td>\n99.58%<\/td>\nCYP3A4 and 2D6 inhibitor,moderate<\/td>\n<\/tr>\n
A3375<\/td>\nDY131<\/td>\n95167-41-2<\/td>\n99.82%<\/td>\nERR\u03b3 agonist<\/td>\n<\/tr>\n
A3378<\/td>\nE-3810<\/td>\n1058137-23-7<\/td>\n98.00%<\/td>\nVEGF\/FGF dual inhibitor, potent and selective<\/td>\n<\/tr>\n
A3380<\/td>\nEbrotidine<\/td>\n100981-43-9<\/td>\n98.00%<\/td>\nH2-receptor antagonist,competitive<\/td>\n<\/tr>\n
A3381<\/td>\nEdoxaban<\/td>\n480449-70-5<\/td>\n99.27%<\/td>\nFactor Xa inhibitor<\/td>\n<\/tr>\n
A3383<\/td>\nEdoxaban tosylate monohydrate<\/td>\n1229194-11-9<\/td>\n99.34%<\/td>\nOral factor Xa inhibitor<\/td>\n<\/tr>\n
A3384<\/td>\nElacridar<\/td>\n143664-11-3<\/td>\n98.17%<\/td>\nBCRP inhibitor<\/td>\n<\/tr>\n
A3385<\/td>\nElacridar hydrochloride<\/td>\n143851-98-3<\/td>\n98.00%<\/td>\nBCRP and P-GP inhibitor<\/td>\n<\/tr>\n
A3387<\/td>\nEltrombopag Olamine<\/td>\n496775-62-3<\/td>\n98.49%<\/td>\nC-mpl agonist<\/td>\n<\/tr>\n
A3389<\/td>\nEMD638683<\/td>\n1181770-72-8<\/td>\n98.46%<\/td>\nSGK1 inhibitor<\/td>\n<\/tr>\n
A3392<\/td>\nEmodin<\/td>\n518-82-1<\/td>\n99.09%<\/td>\nNaturally occurring anthraquinone,antiproliferative<\/td>\n<\/tr>\n
A3394<\/td>\nEpothilone D<\/td>\n189453-10-9<\/td>\n98.00%<\/td>\nNatural polyketide compound<\/td>\n<\/tr>\n
A3395<\/td>\nErcalcidiol<\/td>\n21343-40-8<\/td>\n98.00%<\/td>\nVitamin D2 metabolite,ligand of VDR-like receptors<\/td>\n<\/tr>\n
A3396<\/td>\nErcalcitriol<\/td>\n60133-18-8<\/td>\n98.00%<\/td>\nActive metabolite of vitamin D2<\/td>\n<\/tr>\n
A3397<\/td>\nErlotinib<\/td>\n183321-74-6<\/td>\n99.47%<\/td>\nEGFR tyrosine kinase inhibitor<\/td>\n<\/tr>\n
A3399<\/td>\nEsomeprazole Magnesium trihydrate<\/td>\n217087-09-7<\/td>\n98.32%<\/td>\nProton pump inhibitor<\/td>\n<\/tr>\n
A3401<\/td>\nEtifoxine hydrochloride<\/td>\n56776-32-0<\/td>\n99.87%<\/td>\nGABAA receptor potentiator<\/td>\n<\/tr>\n
A3403<\/td>\nEtofenamate<\/td>\n30544-47-9<\/td>\n98.05%<\/td>\nNon-steroidal anti-inflammatory drug<\/td>\n<\/tr>\n
A3404<\/td>\nEtomoxir<\/td>\n124083-20-1<\/td>\n99.75%<\/td>\n(CPT)-1 and DGAT activity inhibitor<\/td>\n<\/tr>\n
A3405<\/td>\nEtoricoxib<\/td>\n202409-33-4<\/td>\n99.82%<\/td>\nSpecific COX-2 inhibitor<\/td>\n<\/tr>\n
A3407<\/td>\nEVP-6124 hydrochloride<\/td>\n550999-74-1<\/td>\n99.85%<\/td>\nAlpha7 nAChR agonist<\/td>\n<\/tr>\n
A3408<\/td>\nExendin-4<\/td>\n141758-74-9<\/td>\n99.66%<\/td>\nGLP-1 activator<\/td>\n<\/tr>\n
A3411<\/td>\nFaropenem daloxate<\/td>\n141702-36-5<\/td>\n98.00%<\/td>\nOral penem,beta-lactam antibiotic<\/td>\n<\/tr>\n
A3412<\/td>\nFenretinide<\/td>\n65646-68-6<\/td>\n98.00%<\/td>\nSynthetic retinoid agonist<\/td>\n<\/tr>\n
A3413<\/td>\nFH535<\/td>\n108409-83-2<\/td>\n99.62%<\/td>\nWnt\/B-catenin inhibitor<\/td>\n<\/tr>\n
A3415<\/td>\nFirategrast<\/td>\n402567-16-2<\/td>\n99.56%<\/td>\n\u03b14\u03b21\/\u03b14\u03b27 integrin antagonist<\/td>\n<\/tr>\n
A3416<\/td>\nFK 3311<\/td>\n116686-15-8<\/td>\n98.00%<\/td>\nSelective COX-2 inhibitor<\/td>\n<\/tr>\n
A3417<\/td>\nFlavopiridol<\/td>\n146426-40-6<\/td>\n99.52%<\/td>\nPan-cdk inhibitor<\/td>\n<\/tr>\n
A3418<\/td>\nFlecainide acetate<\/td>\n54143-56-5<\/td>\n99.82%<\/td>\nAntiarrhythmic drug<\/td>\n<\/tr>\n
A3419<\/td>\nFluvastatin<\/td>\n93957-54-1<\/td>\n98.33%<\/td>\nHMGCR inhibitor<\/td>\n<\/tr>\n
A3420<\/td>\nFMK<\/td>\n821794-92-7<\/td>\n98.82%<\/td>\nRSK inhibitor<\/td>\n<\/tr>\n
A3421<\/td>\nFosamprenavir Calcium Salt<\/td>\n226700-81-8<\/td>\n99.71%<\/td>\nProdrug of antiretroviral protease inhibitor amprenavir<\/td>\n<\/tr>\n
A3423<\/td>\nGalanthamine<\/td>\n357-70-0<\/td>\n99.12%<\/td>\nAcetylcholinesterase inhibitor<\/td>\n<\/tr>\n
A3424<\/td>\nGambogic Acid<\/td>\n2752-65-0<\/td>\n98.54%<\/td>\nCaspase activator and apoptosis inducer<\/td>\n<\/tr>\n
A3429<\/td>\nGANT 58<\/td>\n64048-12-0<\/td>\n99.38%<\/td>\nGLI antagonist,novel and potent<\/td>\n<\/tr>\n
A3432<\/td>\nGDC-0941 dimethanesulfonate<\/td>\n957054-33-0<\/td>\n99.78%<\/td>\nPI3K inhibitor<\/td>\n<\/tr>\n
A3433<\/td>\nGefitinib hydrochloride<\/td>\n184475-55-6<\/td>\n99.87%<\/td>\nPotent EGFR inhibitor<\/td>\n<\/tr>\n
A3434<\/td>\nGenz-644282<\/td>\n529488-28-6<\/td>\n98.00%<\/td>\nNon-camptothecin inhibitor of topoisomerase I<\/td>\n<\/tr>\n
A3435<\/td>\nglucagon receptor antagonists 1<\/td>\n503559-84-0<\/td>\n98.00%<\/td>\nGlucagon receptor antagonist,highly potent<\/td>\n<\/tr>\n
A3436<\/td>\nglucagon receptor antagonists 2<\/td>\n202917-18-8<\/td>\n98.00%<\/td>\nGlucagon receptor antagonist,highly potent<\/td>\n<\/tr>\n
A3437<\/td>\nglucagon receptor antagonists 3<\/td>\n202917-17-7<\/td>\n98.00%<\/td>\nGlucagon receptor antagonist<\/td>\n<\/tr>\n
A3438<\/td>\nGlucocorticoid receptor agonist<\/td>\n1245526-82-2<\/td>\n98.00%<\/td>\nGlucagon receptor antagonist<\/td>\n<\/tr>\n
A3440<\/td>\nGlyoxalase I inhibitor<\/td>\n221174-33-0<\/td>\n98.00%<\/td>\nGlyoxalase I inhibitor<\/td>\n<\/tr>\n
A3441<\/td>\nGPR120 modulator 1<\/td>\n1050506-75-6<\/td>\n98.00%<\/td>\nGPR120 modulator<\/td>\n<\/tr>\n
A3442<\/td>\nGPR120 modulator 2<\/td>\n1050506-87-0<\/td>\n98.00%<\/td>\nGPR120 modulator<\/td>\n<\/tr>\n
A3443<\/td>\nGranisetron<\/td>\n109889-09-0<\/td>\n98.00%<\/td>\nSerotonin 5-HT3 receptor antagonist<\/td>\n<\/tr>\n
A3444<\/td>\nGS-9620<\/td>\n1228585-88-3<\/td>\n98.01%<\/td>\nTLR-7 agonist<\/td>\n<\/tr>\n
A3445<\/td>\nGSK 525768A<\/td>\n1260530-25-3<\/td>\n98.00%<\/td>\ninactive stereoisomer of I-BET-762<\/td>\n<\/tr>\n
A3446<\/td>\nGSK126<\/td>\n1346574-57-9<\/td>\n98.32%<\/td>\nEZH2 inhibitor<\/td>\n<\/tr>\n
A3448<\/td>\nGSK2606414<\/td>\n1337531-36-8<\/td>\n98.18%<\/td>\nPERK inhibitor,potent and selective<\/td>\n<\/tr>\n
A3449<\/td>\nGSK343<\/td>\n1346704-33-3<\/td>\n98.95%<\/td>\nEZH2 inhibitor,potent,selective and cell permeable<\/td>\n<\/tr>\n
A3450<\/td>\nGSK-923295<\/td>\n1088965-37-0<\/td>\n98.28%<\/td>\nCENP-E inhibitor,small-molecule<\/td>\n<\/tr>\n
A3451<\/td>\nGuanfacine hydrochloride<\/td>\n29110-48-3<\/td>\n99.41%<\/td>\n\u03b12A-adrenoceptor agonist<\/td>\n<\/tr>\n
A3452<\/td>\nGW-1100<\/td>\n306974-70-9<\/td>\n98.00%<\/td>\nGPR40 antagonist<\/td>\n<\/tr>\n
A3453<\/td>\nGW1929<\/td>\n196808-24-9<\/td>\n98.00%<\/td>\nPotent PPAR\u03b3 agonist<\/td>\n<\/tr>\n
A3454<\/td>\nGW3965<\/td>\n405911-09-3<\/td>\n98.00%<\/td>\nHLXR\u03b1\/hLXR\u03b2 agonist,potent and selective<\/td>\n<\/tr>\n
A3456<\/td>\nGW843682X<\/td>\n660868-91-7<\/td>\n98.00%<\/td>\nPLK1\/PLK3 inhibitor,potent and selective<\/td>\n<\/tr>\n
A3460<\/td>\nHhAntag<\/td>\n496794-70-8<\/td>\n98.95%<\/td>\nGLI1-mediated transcription inhibitor<\/td>\n<\/tr>\n
A3461<\/td>\nHIV-1 integrase inhibitor<\/td>\n544467-07-4<\/td>\n98.00%<\/td>\nUesful for anti-HIV<\/td>\n<\/tr>\n
A3465<\/td>\nHOE 33187<\/td>\n23623-08-7<\/td>\n98.00%<\/td>\nBlue fluorescent dyes<\/td>\n<\/tr>\n
A3466<\/td>\nHoechst 33258<\/td>\n23491-45-4<\/td>\n99.88%<\/td>\nBlue fluorescent dyes<\/td>\n<\/tr>\n
A3472<\/td>\nHoechst 33342<\/td>\n875756-97-1<\/td>\n98.84%<\/td>\nBlue fluorescent dyes<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

 <\/p>\n","protected":false},"excerpt":{"rendered":"

\u6297\u83cc\u5291\u7cfb\u5217\u5546\u54c1->>\u6fd5\u9ef4\u7d20(Hygromycin B) APExBIO Technology LL […]<\/p>\n","protected":false},"author":3,"featured_media":34114,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":[],"categories":[5368],"tags":[4941],"_links":{"self":[{"href":"https:\/\/biopioneer.com.tw\/index.php?rest_route=\/wp\/v2\/posts\/34113"}],"collection":[{"href":"https:\/\/biopioneer.com.tw\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/biopioneer.com.tw\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/biopioneer.com.tw\/index.php?rest_route=\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/biopioneer.com.tw\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=34113"}],"version-history":[{"count":6,"href":"https:\/\/biopioneer.com.tw\/index.php?rest_route=\/wp\/v2\/posts\/34113\/revisions"}],"predecessor-version":[{"id":53721,"href":"https:\/\/biopioneer.com.tw\/index.php?rest_route=\/wp\/v2\/posts\/34113\/revisions\/53721"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/biopioneer.com.tw\/index.php?rest_route=\/wp\/v2\/media\/34114"}],"wp:attachment":[{"href":"https:\/\/biopioneer.com.tw\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=34113"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/biopioneer.com.tw\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=34113"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/biopioneer.com.tw\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=34113"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}